La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Telesis Bio a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Telesis Bio..

Telesis Bio (OTC:TBIO) Azioni, Catena delle Opzioni

Telesis Bio

Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.

Telesis Bio Inc

<h3>Gainers</h3>
<ul>
<li>Onconetix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) shares rose 77.0% to $5.94 during Friday's pre-market session. The company's market cap stands at $4.4 million. </li>
<li>Establishment Labs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESTA#NASDAQ">ESTA</a>) stock moved upwards by 28.6% to $52.98. The market value of their outstanding shares is at $1.4 billion. </li>
<li>Cardio Diagnostics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) stock rose 17.89% to $0.29. The market value of their outstanding shares is at $7.0 million. </li>
<li>LakeShore Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSB#NASDAQ">LSB</a>) stock rose 10.25% to $0.86. The market value of their outstanding shares is at $161.5 million. </li>
<li>Certara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) stock increased by 9.77% to $11.75. The market value of their outstanding shares is at $1.8 billion. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares increased by 9.56% to $0.3. The market value of their outstanding shares is at $2.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Theriva Biologics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) shares fell 18.6% to $1.66 during Friday's pre-market session. The company's market cap stands at $2.2 million. </li>
<li>enVVeno Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNO#NASDAQ">NVNO</a>) shares decreased by 17.12% to $3.73. The market value of their outstanding shares is at $49.7 million. </li>
<li>Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) stock fell 16.11% to $2.39. The company's market cap stands at $14.2 million. The company's, Q4 earnings came out yesterday. </li>
<li>Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares declined by 14.29% to $3.42. The market value of their outstanding shares is at $6.0 million. </li>
<li>Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) shares declined by 10.53% to $28.51. The company's market cap stands at $1.3 billion. </li>
<li>Streamline Health Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRM#NASDAQ">STRM</a>) shares fell 10.35% to $0.21. The market value of their outstanding shares is at $13.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AYTU

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CERT

ENSC

ESTA

NVNO

ONCO

SAVA

STRM

TBIO

TOVX

12 Health Care Stocks Moving In Friday's Pre-Market Session

Shares of Establishment Labs Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESTA#NASDAQ">ESTA</a>) rose sharply in today's pre-market as the company received U.S. FDA approval for Motiva Implants.
Establishment Labs Holdings shares jumped 28.3% to $52.88 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Fangdd Network Group Ltd.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) rose 51.3% to $1.62 in pre-market trading after jumping 110% on Thursday.</li>
<li>Onconetix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) shares rose 40.1% to $4.75 in pre-market trading. Onconetix recently announced a 1-for-40 reverse stock split.</li>
<li>The Real Good Food Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGF#NASDAQ">RGF</a>) gained 38.9% to $0.5140 in pre-market trading after announcing debt refinancing transactions with PMC Financial Services and Emblem Investment Fund for a $60 million new term loan.</li>
<li>Expion360 Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) rose 30.2% to $0.0840 in pre-market trading after declining around 23% on Thursday.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) shares rose 26.5% to $0.3162 in pre-market trading after falling around 5% on Thursday.</li>
<li>Mercurity Fintech Holding Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) shares surged 16% to $1.60 in pre-market trading after falling around 4% on Thursday.</li>
<li>Sonim Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) shares gained 10.1% to $3.27 in pre-market trading. Sonim Technologies recently announced a strategic distribution partnership with TCCM.</li>
<li>IonQ, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NASDAQ">IONQ</a>) gained 7% to $8.62 in pre-market trading after the company said it inked $54.5 million contract with the United States Air Force Research Lab.</li>
<li>Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) shares jumped 6.3% to $53.29 in pre-market trading as the company said the U.S. FDA has approved COBENFY&#x2122; (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Volato Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#NYSE">SOAR</a>) shares dipped 19% to $0.4156 in pre-market trading after jumping 83% on Thursday.</li>
<li>enVVeno Medical Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNO#NASDAQ">NVNO</a>) fell 16.4% to $3.76 in pre-market trading after announcing a proposed public offering.</li>
<li>Momentus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares fell 16% to $0.4504 in pre-market trading after the company received non-compliance notice from Listing Qualifications Department of Nasdaq.</li>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) fell 13.8% to $0.2058 in pre-market trading after gaining more than 7% on Thursday.</li>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares declined 12.8% to $3.48 in pre-market trading. Telesis Bio shares jumped 72% on Thursday after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.</li>
<li>Theriva Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#NASDAQ">TOVX</a>) shares fell 11.8% to $1.80 in pre-market trading after the company announced the pricing of $2.5 million public offering.</li>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) declined 10.8% to $28.40 in pre-market trading after the SEC charged the company, two former executives for misleading claims about Alzheimer&#8217;s clinical trial.</li>
<li>AtlasClear Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NASDAQ">ATCH</a>) shares declined 9.8% to $0.2643 in pre-market trading.</li>
<li>Gryphon Digital Mining, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) fell 9.6% to $0.5533 in today's pre-market trading after gaining 10% on Thursday.</li>
<li>HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) shares fell 3.2% to $35.70 in pre-market trading after gaining over 2% on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/41061511/costco-scholastic-and-3-stocks-to-watch-heading-into-friday">Costco, Scholastic And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

News

Markets

Trading Ideas

ATCH

GRYP

IONQ

MBIO

MNTS

SOAR

SONM

XPON

Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Cardio Diagnostics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) stock increased by 16.8% to $0.29 during Thursday's after-market session. The company's market cap stands at $6.9 million. </li>
<li>TC BioPharm (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) stock rose 6.69% to $6.16. The market value of their outstanding shares is at $3.1 million. </li>
<li>Seres Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) shares moved upwards by 6.01% to $0.88. The company's market cap stands at $134.0 million. </li>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares moved upwards by 5.88% to $1.08. The company's market cap stands at $6.2 million. </li>
<li>BioVie (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>) stock moved upwards by 5.4% to $1.17. The company's market cap stands at $7.1 million. </li>
<li>China Pharma Holdings, Inc. Common Stock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) stock rose 5.2% to $0.26. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cue Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>) shares decreased by 27.8% to $0.33 during Thursday's after-market session. The company's market cap stands at $15.9 million. </li>
<li>enVVeno Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNO#NASDAQ">NVNO</a>) stock declined by 15.34% to $3.81. The market value of their outstanding shares is at $50.7 million. </li>
<li>Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) stock decreased by 7.04% to $3.7. The market value of their outstanding shares is at $6.5 million. </li>
<li>Streamline Health Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRM#NASDAQ">STRM</a>) shares declined by 6.17% to $0.21. The company's market cap stands at $13.3 million. </li>
<li>Lipella Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) stock fell 5.38% to $0.48. The market value of their outstanding shares is at $3.8 million. </li>
<li>Travere Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) shares declined by 5.12% to $14.27. The market value of their outstanding shares is at $1.0 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIVI

CHRO

CPHI

LIPO

MCRB

TCBP

TVTX

12 Health Care Stocks Moving In Thursday's After-Market Session

U.S. stocks traded higher toward the end of trading, with the Dow Jones index rising more than 250 points on Thursday.
The Dow traded up 0.63% to 42,177.28 while the NASDAQ rose 0.54% to 18,179.88. The S&amp;P 500 also rose, gaining, 0.36% to 5,743.03.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/09/41045161/how-to-earn-500-a-month-from-costco-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Costco Stock Ahead Of Q4 Earnings</a>
Leading and Lagging Sectors Materials shares jumped by 1.9% on Thursday.
In trading on Thursday, energy shares fell by 2%.
Top Headline
Accenture Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) reported better-than-expected earnings for its fourth quarter.
The company posted quarterly sales of $16.41 billion compared with the analyst consensus estimate of $16.39 billion, up 3% Y/Y in U.S. dollars and 5% in local currency. The adjusted EPS of $2.79 topped the analyst consensus estimate of $2.77.
Accenture declared a quarterly cash dividend of $1.48 per share, implying a growth of 15%. The board approved $4.0 billion in additional share repurchase authority, bringing Accenture's total outstanding authority to approximately $6.7 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares shot up 43% to $3.31 after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.</li>
<li>Shares of Pasithea Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) got a boost, surging 62% to $6.24 after the company announced safety, tolerability, pharmacokinetic and preliminary efficacy data from the first 2 cohorts of patients in its Phase 1 clinical trial of PAS-004.</li>
<li>Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) shares were also up, gaining 11% to $125.56 after the company reported better-than-expected fourth-quarter financial results and approved a $1 billion share buyback.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) shares dropped 16% to $53.29 following mixed third-quarter financial results.</li>
<li>Shares of Ryde Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NYSE">RYDE</a>) were down 32% to $0.7792 after the company announced a $4.5 million public offering at $0.85 per unit.</li>
<li>MDxHealth SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) was down, falling 21% to $2.00 after the company announced the pricing of a $40 million offering of 20 million shares at $2.00 per share</li>
</ul>
Commodities In commodity news, oil traded down 2.5% to $67.95 while gold traded up 0.2% at $2,690.70.
Silver traded up 0.9% to $32.315 on Thursday, while copper rose 3.1% to $4.6290.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 gained 1.25%, Germany's DAX climbed 1.69% and France's CAC 40 jumped 2.33%. Spain's IBEX 35 Index rose 1.36%, while London's FTSE 100 rose 0.20%.
Bank lending to households in the Eurozone increased by 0.6% year-over-year to €6.891 trillion in August compared to a 0.5% rise in the prior month. The GfK Consumer Climate Indicator for Germany climbed to a reading of -21.2 heading into October versus a revised reading of -21.9 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 jumping 2.79%, Hong Kong's Hang Seng Index jumping 4.16%, China's Shanghai Composite Index gaining 3.61% and India's BSE Sensex gaining 0.78%.
Hong Kong&#8217;s trade deficit widened to $33.1 billion in August versus $25.6 billion in the year-ago month.
Economics
<ul>
<li>U.S. core PCE prices increased by 2.8% from the prior quarter during the second quarter compared to a 3.7% gain in the previous period.</li>
<li>U.S. durable goods orders came in mostly unchanged from the previous month in August versus the revised 9.8% jump in the earlier period.</li>
<li>U.S. initial jobless claims fell by 4,000 from the prior week to 218,000 during the period ending September 21, compared to estimates of 225,000.</li>
<li>The US economy expanded at an annualized rate of 3% during the second quarter versus a revised 1.6% increase in the first quarter.</li>
<li>Pending home sales in the U.S. rose by 0.6% from the prior month in August versus market estimates of a 0.3% increase.</li>
<li>U.S. natural-gas stocks rose 47 billion cubic feet in the week ended Sept. 20, compared to market estimates of a 52 bcf gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/41045737/top-3-materials-stocks-youll-regret-missing-this-quarter">Top 3 Materials Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

CNXC

KTTA

MDXH

RYDE

Dow Surges Over 250 Points; Accenture Earnings Top Views

Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares are moving higher on Thursday after the company announced a partnership with Beckman <a href="https://www.benzinga.com/news/24/09/41042264/why-telesis-bio-shares-are-trading-higher-by-around-110-here-are-20-stocks-moving-premarket">Coulter Life Sciences</a>.
The partnership integrates Telesis Bio&#8217;s Gibson SOLA Enzymatic Synthesis technology with the Biomek Echo One System from Beckman Coulter Life Sciences.
&#8220;By integrating Gibson SOLA&#8217;s high-fidelity, scalable, and non-toxic DNA synthesis capabilities with Beckman Coulter Life Sciences automation expertise, we are setting a new standard for on-premises biofoundries&#8221;, said Eric Esser, CEO of Telesis Bio.
How To Buy Telesis Bio Shares
By now you're likely curious about how to participate in the market for Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
See Also: <a href="https://www.benzinga.com/general/biotech/24/09/41013215/edgewise-therapeutics-soars-50-key-reasons-behind-the-surge">Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge</a>
TBIO Price Action: At the time of writing, Telesis stock is trading 41.4% higher at $3.28, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Shutterstock

What's Going On With Telesis Bio Shares Thursday?

<h3>Gainers</h3>
<ul>
<li>Pasithea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) stock moved upwards by 66.4% to $6.4 during Thursday's regular session. The market value of their outstanding shares is at $6.6 million. </li>
<li>Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares increased by 49.13% to $3.46. The market value of their outstanding shares is at $6.1 million. </li>
<li>Adaptive Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) shares rose 28.62% to $5.14. The company's market cap stands at $758.7 million. </li>
<li>Fulcrum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULC#NASDAQ">FULC</a>) stock increased by 25.64% to $4.36. The company's market cap stands at $272.0 million. </li>
<li>Eterna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) stock increased by 20.3% to $1.25. The market value of their outstanding shares is at $6.7 million. </li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) stock rose 18.51% to $7.04. The market value of their outstanding shares is at $368.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) stock decreased by 19.4% to $1.75 during Thursday's regular session. The market value of their outstanding shares is at $91.3 million. As per the news, the H1 earnings report came out yesterday. </li>
<li>Theriva Biologics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) shares declined by 18.99% to $1.92. The company's market cap stands at $2.5 million. </li>
<li>Forte Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) shares decreased by 14.47% to $5.64. The market value of their outstanding shares is at $8.2 million. </li>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares declined by 13.31% to $8.34. The company's market cap stands at $13.0 million. </li>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares fell 11.02% to $0.6. The company's market cap stands at $4.5 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) stock decreased by 10.17% to $1.67. The market value of their outstanding shares is at $21.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADPT

ERNA

FBRX

FULC

KAPA

LUCY

12 Health Care Stocks Moving In Thursday's Intraday Session

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday.
The Dow traded up 0.47% to 42,110.56 while the NASDAQ rose 0.19% to 18,117.40. The S&amp;P 500 also rose, gaining, 0.21% to 5,734.09.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/09/41045161/how-to-earn-500-a-month-from-costco-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Costco Stock Ahead Of Q4 Earnings</a>
Leading and Lagging Sectors Materials shares jumped by 1.8% on Thursday.
In trading on Thursday, energy shares fell by 1.9%.
Top Headline
U.S. initial jobless claims fell by 4,000 from the prior week to 218,000 during the period ending September 21, compared to estimates of 225,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares shot up 71% to $3.96 after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.</li>
<li>Shares of Pasithea Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) got a boost, surging 66% to $6.37 after the company announced safety, tolerability, pharmacokinetic and preliminary efficacy data from the first 2 cohorts of patients in its Phase 1 clinical trial of PAS-004.</li>
<li>Adaptive Biotechnologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) shares were also up, gaining 25% to $5.00.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) shares dropped 16% to $53.65 following mixed third-quarter financial results.</li>
<li>Shares of Ryde Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NYSE">RYDE</a>) were down 30% to $0.81 after the company announced a $4.5 million public offering at $0.85 per unit.</li>
<li>MDxHealth SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) was down, falling 21% to $2.00 after the company announced the pricing of a $40 million offering of 20 million shares at $2.00 per share</li>
</ul>
Commodities In commodity news, oil traded down 2.4% to $68.00 while gold traded up 0.2% at $2,688.80.
Silver traded up 1.3% to $32.435 on Thursday, while copper rose 2.9% to $4.6195.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 1.13%, Germany's DAX climbed 1.52% and France's CAC 40 jumped 2.08%. Spain's IBEX 35 Index rose 1.39%, while London's FTSE 100 rose 0.12%.
Bank lending to households in the Eurozone increased by 0.6% year-over-year to €6.891 trillion in August compared to a 0.5% rise in the prior month. The GfK Consumer Climate Indicator for Germany climbed to a reading of -21.2 heading into October versus a revised reading of -21.9 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 jumping 2.79%, Hong Kong's Hang Seng Index jumping 4.16%, China's Shanghai Composite Index gaining 3.61% and India's BSE Sensex gaining 0.78%.
Hong Kong&#8217;s trade deficit widened to $33.1 billion in August versus $25.6 billion in the year-ago month.
Economics
<ul>
<li>U.S. core PCE prices increased by 2.8% from the prior quarter during the second quarter compared to a 3.7% gain in the previous period.</li>
<li>U.S. durable goods orders came in mostly unchanged from the previous month in August versus the revised 9.8% jump in the earlier period.</li>
<li>U.S. initial jobless claims fell by 4,000 from the prior week to 218,000 during the period ending September 21, compared to estimates of 225,000.</li>
<li>The US economy expanded at an annualized rate of 3% during the second quarter versus a revised 1.6% increase in the first quarter.</li>
<li>Pending home sales in the U.S. rose by 0.6% from the prior month in August versus market estimates of a 0.3% increase.</li>
<li>U.S. natural-gas stocks rose 47 billion cubic feet in the week ended Sept. 20, compared to market estimates of a 52 bcf gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/41045737/top-3-materials-stocks-youll-regret-missing-this-quarter">Top 3 Materials Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Intraday Update

Crude Oil Down Over 2%; US Initial Jobless Claims Fall

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 1% on Thursday.
Following the market opening Thursday, the Dow traded up 0.65% to 42,187.74 while the NASDAQ rose 1.13% to 18,285.75. The S&amp;P 500 also rose, gaining, 0.65% to 5,759.58.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/09/41045161/how-to-earn-500-a-month-from-costco-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Costco Stock Ahead Of Q4 Earnings</a>
Leading and Lagging Sectors Materials shares jumped by 1.5% on Thursday.
In trading on Thursday, energy shares fell by 1.4%.
Top Headline
Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) reported better-than-expected fourth-quarter financial results.
The company reported fourth-quarter revenue of $7.75 billion, beating the consensus estimate of $7.635 billion. The company reported fourth-quarter adjusted earnings of $1.18 per share, beating analyst estimates of $1.13 per share, according to Benzinga Pro
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares shot up 102% to $4.68 after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.</li>
<li>Shares of Pasithea Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) got a boost, surging 75% to $6.80 after the company announced safety, tolerability, pharmacokinetic and preliminary efficacy data from the first 2 cohorts of patients in its Phase 1 clinical trial of PAS-004.</li>
<li>Fangdd Network Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) shares were also up, gaining 61% to $0.8210.</li>
</ul>
Equities Trading DOWN
<ul>
<li>VS MEDIA Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) shares dropped 30% to $1.0599 after jumping 22% on Wednesday.</li>
<li>Shares of Ryde Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NYSE">RYDE</a>) were down 30% to $0.8038 after the company announced a $4.5 million public offering at $0.85 per unit.</li>
<li>MDxHealth SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) was down, falling 21% to $1.9999 after the company announced the pricing of a $40 million offering of 20 million shares at $2.00 per share</li>
</ul>
Commodities In commodity news, oil traded down 2.4% to $68.00 while gold traded up 0.6% at $2,699.50.
Silver traded up 1.8% to $32.605 on Thursday, while copper rose 2.1% to $4.5845.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 1.2%, Germany's DAX climbed 1.4% and France's CAC 40 jumped 1.9%. Spain's IBEX 35 Index rose 1.4%, while London's FTSE 100 rose 0.3%.
Bank lending to households in the Eurozone increased by 0.6% year-over-year to €6.891 trillion in August compared to a 0.5% rise in the prior month. The GfK Consumer Climate Indicator for Germany climbed to a reading of -21.2 heading into October versus a revised reading of -21.9 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 jumping 2.79%, Hong Kong's Hang Seng Index jumping 4.16%, China's Shanghai Composite Index gaining 3.61% and India's BSE Sensex gaining 0.78%.
Hong Kong&#8217;s trade deficit widened to $33.1 billion in August versus $25.6 billion in the year-ago month.
Economics
<ul>
<li>U.S. core PCE prices increased by 2.8% from the prior quarter during the second quarter compared to a 3.7% gain in the previous period.</li>
<li>U.S. durable goods orders came in mostly unchanged from the previous month in August versus the revised 9.8% jump in the earlier period.</li>
<li>U.S. initial jobless claims fell by 4,000 from the prior week to 218,000 during the period ending September 21, compared to estimates of 225,000.</li>
<li>The US economy expanded at an annualized rate of 3% during the second quarter versus a revised 1.6% increase in the first quarter.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/41045737/top-3-materials-stocks-youll-regret-missing-this-quarter">Top 3 Materials Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

VSME

Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results

WIIM

Telesis Bio Partners shares are trading higher after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.

MU: 17% &#x7C; <a href="https://www.benzinga.com//node/41043790">Micron shares are trading higher following better-than-expected Q4 financial results.</a>
&nbsp;
TBIO: 148% &#x7C; <a href="https://www.benzinga.com//node/41034325">Telesis Bio Partners With Beckman Coulter Life Sciences To Revolutionize DNA And mRNA Synthesis, Enabling Scalable, High-Fidelity Biofoundries Through Automated Gibson SOLA Enzymatic Reagent Platform</a>
&nbsp;
KTTA: 69% &#x7C; <a href="https://www.benzinga.com//node/41043064">Pasithea Therapeutics Announced Safety, Tolerability, Pharmacokinetic And Preliminary Efficacy Data From The First 2 Cohorts Of Patients In Its Phase 1 Clinical Trial Of PAS-004</a>

Market-Moving News for September 26th

Shares of Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) rose sharply in today's pre-market trading session after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.
Telesis Bio reached a new partnership with laboratory automation and innovation company Beckman Coulter Life Sciences to create efficient and scalable biofoundries and deliver<a href="https://www.benzinga.com/general/biotech/24/09/41035436/telesis-bio-stock-is-soaring-wednesday-whats-going-on"> solutions for DNA synthesis</a>.
Telesis Bio shares jumped 109.9% to $4.87 in the pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Kintara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) rose 41.8% to $0.2375 in pre-market trading. Kintara Therapeutics recently announced adjournment of special meeting of stockholders until Oct. 4.</li>
<li>Fangdd Network Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) shares rose 22.3% to $0.6234 in pre-market trading after declining 7% on Friday.</li>
<li>NuCana plc  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) gained 20.7% to $3.68 in pre-market trading after the company announced a U.S. patent grant covering its NUC-7738 composition-of-matter.</li>
<li>Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) gained 15.5% to $110.61 in pre-market as the company reported better-than-expected fourth-quarter financial results. The company reported fourth-quarter revenue of $7.75 billion, beating the consensus estimate of $7.635 billion. The company reported fourth-quarter adjusted earnings of $1.18 per share, beating analyst estimates of $1.13 per share, according to Benzinga Pro.</li>
<li>Gaotu Techedu Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOTU#NYSE">GOTU</a>) shares rose 14.8% to $3.34 in pre-market trading after falling around 5% on Wednesday.</li>
<li>Sonnet BioTherapeutics Holdings, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) rose 14.2% to $0.83 in pre-market trading. Sonnet BioTherapeutics shares dipped 20% on Wednesday after the company announced a 1-for-8 reverse stock split.</li>
<li>MicroCloud Hologram Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) shares gained 13.6% to $0.2737 in pre-market trading after rising around 5% on Wednesday.</li>
<li>Kanzhun Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) shares surged 13.5% to $16.20 in pre-market trading after falling 6% on Wednesday.</li>
<li>American Lithium Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLI#NASDAQ">AMLI</a>) gained 8.7% to $0.5297 in pre-market trading after gaining over 11% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>VS MEDIA Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) fell 23.6% to $1.16 in pre-market trading after jumping 22% on Wednesday.</li>
<li>MDxHealth SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) shares dipped 20.9% to $2.01 in pre-market trading after the company reported the pricing of offering of ordinary shares.</li>
<li>Pagaya Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGY#NASDAQ">PGY</a>) shares fell 15% to $10.59 in pre-market trading after the company announced its intention to offer $125 million of exchangeable senior notes due 2029 in a private offering.</li>
<li>AtlasClear Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NASDAQ">ATCH</a>) fell 14.5% to $0.2547 in pre-market trading. AtlasClear Holdings named Mark S. Smith as a Board Member.</li>
<li>Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) shares declined 13.8% to $54.79 in pre-market trading following mixed third-quarter financial results.</li>
<li>NLS Pharmaceutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NLSP#NASDAQ">NLSP</a>) shares fell 13.8% to $0.11 in pre-market trading. NLS Pharmaceutics, on Wednesday, announced expected implementation of 1-for-40 reverse share split.</li>
<li>Seelos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEEL#NASDAQ">SEEL</a>) fell 13.4% to $0.2928 in today's pre-market trading after gaining 13% on Wednesday. The company announced a 1-for-16 reverse stock split.</li>
<li>ConnectM Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) shares declined 12.3% to $1.00 in pre-market trading after declining 10% on Wednesday.</li>
<li>Armada Hoffler Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHH#NYSE">AHH</a>) declined 7.3% to $11.00 in pre-market trading. Armada Hoffler announced upsizing and pricing of public offering of common stock.</li>
<li>Sonos, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONO#NASDAQ">SONO</a>) shares fell 6% to $11.86 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41024505/top-5-industrials-stocks-that-may-collapse-in-q3">Top 5 Industrials Stocks That May Collapse In Q3</a></li>
</ul>

Pre-Market Outlook

AMLI

CNTM

GSX Techedu Inc. American Depositary Shares

GOTU

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

Kintara Therapeutics, Inc. - Common Stock

KTRA

NCNA

NLSP

SEEL

SONN

SONO

Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket

Telesis Bio Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares are soaring in extended trading Wednesday after the company announced a partnership to <a href="https://www.benzinga.com/pressreleases/24/09/g41034251/telesis-bio-and-beckman-coulter-life-sciences-collaborate-to-revolutionize-dna-and-mrna-synthesis">revolutionize DNA and mRNA synthesis</a>.
What Happened: Telesis Bio reached a new partnership with laboratory automation and innovation company Beckman Coulter Life Sciences to create efficient and scalable biofoundries and deliver solutions for DNA synthesis.
The partnership will integrate Telesis Bio&#8217;s Gibson SOLA Enzymatic Synthesis technology with Beckman Coulter&#8217;s new Biomek Echo One System, further expanding its flexibility to synthesize biology.
&#8220;This partnership marks a significant milestone in advancing synthetic biology. By integrating Gibson SOLA&#8217;s high-fidelity, scalable, and non-toxic DNA synthesis capabilities with Beckman Coulter Life Sciences automation expertise, we are setting a new standard for on-premises biofoundries,&#8221; said Eric Esser, CEO of Telesis Bio.
&#8220;This collaboration empowers researchers to greatly improve productivity through faster, more reliable and innovative solutions, driving forward the next generation of therapeutic and diagnostic advancements.&#8221;
See Also: <a href="https://www.benzinga.com/news/earnings/24/09/41034733/micron-q4-earnings-revenue-eps-beat-on-robust-ai-demand-company-sees-significantly-improved-profita">Micron Q4 Earnings: Revenue, EPS Beat On &#8216;Robust AI Demand,&#8217; Company Sees &#8216;Significantly Improved&#8217; Profitability Ahead, Shares Surge</a>
Telesis Bio provides non-toxic, high-fidelity and scalable DNA synthesis, empowering scientists to create novel, synthetic biology-enabled solutions.
Telesis Bio is considered a low-float stock with approximately 406,000 shares available for public trading, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. It also had a market cap of less than $5 million as of Wednesday&#8217;s close. Low-float, micro-cap stocks often trade with elevated volatility, which may help explain some of Telesis Bio&#8217;s massive move after the bell.
TBIO Price Action: <a href="http://benzinga.com/quote/tbio">Telesis Bio shares</a> were up 110.02% at $4.87 in after-hours trading Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
This illustration was generated using artificial intelligence via Midjourney.

Biotech

Contracts

After-Hours Center

General

Telesis Bio Stock Is Soaring Wednesday: What's Going On?

Telesis Bio Partners With Beckman Coulter Life Sciences To Revolutionize DNA And mRNA Synthesis, Enabling Scalable, High-Fidelity Biofoundries Through Automated Gibson SOLA Enzymatic Reagent Platform

U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 400 points on Thursday.
Following the market opening Thursday, the Dow traded up 1.44% to 42,100.00 while the NASDAQ rose 2.30% to 17,976.85. The S&amp;P 500 also rose, gaining, 1.65% to 5,710.85.
Check This Out: <a href="https://www.benzinga.com/news/24/09/40937584/alphabet-mcdonalds-and-2-other-stocks-executives-are-selling">Alphabet, McDonald&#8217;s And 2 Other Stocks Executives Are Selling</a>
Leading and Lagging Sectors Information technology shares jumped by 2.7% on Thursday.
In trading on Thursday, utilities shares fell by 0.1%.
Top Headline
U.S. initial jobless claims fell by 12,000 from the prior week to 219,000 in the week ending September 14, compared to market expectations of 230,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares shot up 245% to $4.67. Telesis Bio recently announced that it has notified the Nasdaq Stock Market of its decision to delist.</li>
<li>Shares of Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) got a boost, surging 185% to $0.3702 after the company announced it will acquire sports gaming technology company Swifty Global.</li>
<li>Zeo Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) shares were also up, gaining 153% to $2.96 after declining around 9% on Wednesday.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Haoxi Health Technology Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) shares dropped 74% to $0.77. Haoxi Health Technology announced the pricing of a $12 million underwritten follow-on public offering of 4 million units at a price of $3/unit.</li>
<li>Shares of Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) were down 39% to $14.96 after a client elected to exercise an option to terminate its services agreement with the company.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) was down, falling 23% to $3.19 after the company announced a $4.3 million registered offering of 1.36 million shares of common stock at $3.15 per share.</li>
</ul>
Commodities In commodity news, oil traded up 1.1% to $71.71 while gold traded up 0.2% at $2,602.70.
Silver traded up 2.2% to $31.355 on Thursday, while copper rose 1.7% to $4.3720.
Euro zone
European shares were higher today. The eurozone's STOXX 600 climbed 1.4%, Germany's DAX climbed 1.6% and France's CAC 40 jumped 2%. Spain's IBEX 35 Index rose 0.7%, while London's FTSE 100 rose 1%.
The Bank of England maintained the Bank Rate at 5% during its September meeting, after cutting rates by 25 bps in August. The current account surplus in the Eurozone increased to €48 billion in July from €25.5 billion in the year-ago period.
Asia Pacific Markets
Asian markets closed higher on Thursday, with Japan's Nikkei 225 gaining 2.13%, Hong Kong's Hang Seng Index surging 2%, China's Shanghai Composite Index gaining 0.69% and India's BSE Sensex gaining 0.29%.
Hong Kong's unemployment rate came in unchanged at 3% in the three months ending August. The Hong Kong Monetary Authority cut its base rate by 50bps to 5.25% at its recent meeting.
Economics
<ul>
<li>The U.S. reported a current account deficit of $266.8 billion in the second quarter versus a gap of $241 billion in the prior period and higher than market estimates of a $260 billion gap.</li>
<li>U.S. initial jobless claims fell by 12,000 from the prior week to 219,000 in the week ending September 14, compared to market expectations of 230,000.</li>
<li>The Philadelphia Fed Manufacturing Index climbed to 1.7 in September from -7 in the previous month and topping market estimates of -1.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40937617/top-3-defensive-stocks-you-may-want-to-dump-in-september">Top 3 Defensive Stocks You May Want To Dump In September</a></li>
</ul>

PGNY

VVOS

Nasdaq Surges 400 Points; US Jobless Claims Fall To 219,000

Shares of Exicure, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) rose sharply in today's pre-market trading after the company announced it received an extension <a href="https://www.benzinga.com/general/biotech/24/09/40928868/exicure-stock-is-soaring-after-the-bell-whats-driving-the-action">from the Nasdaq Hearings Panel.</a>
After the market close, Exicure announced that it was granted an extension for continued listing on the Nasdaq exchange. The early-stage biotechnology company must now show compliance with all applicable criteria for continued listing on the Nasdaq by Nov. 14.
Exicure shares jumped 179.9% to $6.41 in the pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Zeo Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) gained 288.9% to $4.55 in pre-market trading after declining around 9% on Wednesday.</li>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) gained 138.4% to $3.22 in the pre-market trading session. Telesis Bio recently announced that it has notified the Nasdaq Stock Market of its decision to delist.</li>
<li>Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) gained 82.8% to $0.9188 in pre-market trading after the company announced Australian regulatory approval for Venus Bliss MAX.</li>
<li>Freight Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) rose 60.6% to $0.1991 in pre-market trading after gaining 12% on Wednesday. Freight Technologies was recently selected by Bayer CropScience as a logistics provider for 2025 and was awarded six essential cross-border lanes to provide truckload services.</li>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares rose 25.6% to $1.37 in pre-market trading after gaining 18% on Wednesday.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMN#NASDAQ">PMN</a>) gained 20.2% to $1.49 in pre-market trading after declining 5% on Wednesday.</li>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) gained 17.4% to $0.1067 in pre-market trading after gaining more than 5% on Wednesday.</li>
<li>Graphjet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) rose 17.4% to $3.00 in pre-market trading after gaining around 12% on Wednesday.</li>
<li>XCHG Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) shares gained 13.2% to $20.80 in pre-market trading after jumping over 65% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) fell 23.2% to $18.78 in pre-market trading.</li>
<li>Webuy Global Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) fell 17.4% to $0.1523 in pre-market trading after surging around 59% on Wednesday.</li>
<li>Veea Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEA#NASDAQ">VEEA</a>) shares fell 15.8% to $10.31 in pre-market trading. Veea shares jumped 131% on Wednesday after the company announced a strategic partnership with Crowdkeep to integrate their respective technologies into a singular, tailored solution to track assets, people, and conditions across a variety of use cases.</li>
<li>1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) shares dipped 15% to $1.70 in pre-market trading after declining 13% on Wednesday.</li>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) shares declined 12% to $0.15 in pre-market trading after dipping 27% on Wednesday.</li>
<li>Allarity Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) shares declined 11.2% to $2.04 in pre-market trading following a 23% decline on Wednesday.</li>
<li>Singularity Future Technology Ltd.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) declined 11.2% to $1.86 in pre-market trading after gaining around 35% on Wednesday.</li>
<li>Odyssey Marine Exploration, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) fell 9.3% to $1.27 in today's pre-market trading after jumping 182% on Wednesday. The company recently announced an award in its arbitration with the United Mexican States under Chapter Eleven of the North American Free Trade Agreement (NAFTA).</li>
<li>Smith Micro Software Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) shares fell 9.3% to $0.92 in pre-market trading after jumping around 6% on Wednesday.</li>
<li>Steelcase Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) shares fell 8.9% to $12.85 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

ALLR

EFSH

FRGT

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MYNA

OMEX

SGLY

SMSI

VEEA

VERO

WBUY

XCUR

Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket

Shares of Champions Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>) rose sharply in today's pre-market trading reported better-than-expected financial results for the <a href="https://www.benzinga.com/quote/CSBR/earnings">first quarter on Wednesday.</a>
The company reported quarterly earnings of 11 cents per share which beat the analyst consensus estimate of a loss of $0.3 per share.
Champions Oncology shares jumped 13.5% to $4.55 in the pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Smart for Life, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMFL#NASDAQ">SMFL</a>) gained 89.4% to $1.61 in pre-market trading. HRT Financial LP acquired a new stake in Smart for Life.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) rose 58% to $1.58 in today's pre-market trading.</li>
<li>N2OFF, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) gained 42.4% to $0.4273 in the pre-market trading session after the company announced a potential 10% increase in capacity for its Solar PV Joint Venture Project with Solterra Renewable Energy.</li>
<li>NETGEAR, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTGR#NASDAQ">NTGR</a>) shares gained 27.8% to $20.37 in pre-market trading after the company disclosed a settlement agreement with TP-Link Systems and raised its third-quarter revenue guidance.</li>
<li>Perfect Moment Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMNT#NASDAQ">PMNT</a>) gained 18.6% to $1.15 in pre-market trading after declining around 8% on Wednesday.</li>
<li>Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) gained 14.4% to $0.1419 in pre-market trading.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) rose 13.8% to $0.1983 in pre-market trading after dipping 14% on Wednesday. Pineapple Energy recently entered into exchange agreements to swap Series A preferred stock and warrants for Series C preferred stock, convertible at $0.45 per share.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) rose 8.7% to $3.94 in pre-market trading. ImmunityBio recently presented long-term overall survival data in non-small cell lung cancer patients and announced registrational intent Phase 3 trials with ANKTIVA and checkpoint immunotherapy at the World Conference on Lung Cancer.</li>
<li>Applied Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) gained 5% to $5.47 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Ryde Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NYSE">RYDE</a>) fell 61.7% to $5.02 in pre-market trading after dipping more than 35% on Wednesday.</li>
<li>Syra Health Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) fell 48.4% to $0.4128 in pre-market trading. Syra Health priced its $2.1 million public offering with shares and warrants priced at $0.64 each.</li>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares dipped 40% to $1.02 in pre-market trading. Telesis Bio shares dipped 55% on Wednesday after the company announced that it has notified the Nasdaq Stock Market of its decision to delist.</li>
<li>CN Energy Group. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>) shares fell 25.9% to $1.03 in pre-market trading. CN Energy Group received Nasdaq notice that it is currently not in compliance with certain requirements under relevant listing rules.</li>
<li>SMX (Security Matters) Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares declined 17.7% to $2.59 in pre-market trading after the company announced a $5.35 million private placement.</li>
<li>FTC Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCI#NASDAQ">FTCI</a>) shares fell 16.4% to $0.3841 in pre-market trading. FTC Solar shares jumped 104% on Wednesday after the company announced that it has been selected by Strata Clean Energy to supply approximately 500 megawatts of its Voyager 2P solar tracker technology for multiple project sites in the U.S. and will be the preferred 2P solar tracker supplier over a three-year initial term.</li>
<li>iSpecimen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) fell 14.5% to $0.21 in today's pre-market trading after the company announced a 1-for-20 reverse stock split.</li>
<li>Oxford Industries, Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) shares declined 10.3% to $75.02 in pre-market trading after the company reported weaker-than-expected earnings and sales results for the second quarter. The company said it sees FY24 net sales of $1.51 billion to $1.54 billion and adjusted earnings of $7 to $7.30 per share.</li>
<li>Cadrenal Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>) shares fell 8.6% to $7.73 in pre-market trading after jumping around 18% on Wednesday.</li>
<li>BeiGene, Ltd.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGNE#NASDAQ">BGNE</a>) declined 6.8% to $196.80 in pre-market trading after gaining around 7% on Wednesday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/09/40813043/jim-cramer-not-the-time-to-own-oil-when-asked-about-exxon-mobil-says-ibm-is-performing-well">Jim Cramer: &#8216;Not The Time To Own Oil,&#8217; When Asked About Exxon Mobil; Says IBM Is &#8216;Performing Well&#8217;</a></li>
</ul>

APLT

BGNE

CNEY

CSBR

CVKD

FTCI

IBRX

ISPC

NITO

NTGR

PEGY

PMNT

PTIX

SMFL

SYRA

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Wednesday.
The Dow traded down 0.25% to 40,634.47 while the NASDAQ rose 1.43% to 17,269.59. The S&amp;P 500 also rose, gaining, 0.40% to 5,517.65.
Check This Out: <a href="https://www.benzinga.com/news/24/09/40812617/wall-streets-most-accurate-analysts-give-their-take-on-3-materials-stocks-delivering-high-dividend-y">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Information technology shares rose by 1.4% on Wednesday.
In trading on Wednesday, consumer staples shares dipped by 1.3%.
Top Headline
The EIA said crude oil inventories in the U.S. increased by 0.833 million barrels during the week ended Sept. 6, compared to market estimates of a 1 million rise.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) shares shot up 38% to $6.45 after the company announced financing transaction and Ironton production update.</li>
<li>Shares of BriaCell Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCTX#NASDAQ">BCTX</a>) got a boost, surging 11% to $0.69 after the company announced overall survival data of its Phase 2 clinical study of Bria-IMT in combination with an immune check point inhibitor in late stage metastatic breast cancer.</li>
<li>Liquidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) shares were also up, gaining 13% to $10.05 after the company announced it raised $67.5 million from the common stock financing of 6,460,674 shares at $8.90 per share.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares dropped 59% to $1.5688 after the company announced that it has notified the Nasdaq Stock Market of its decision to delist.</li>
<li>Shares of Rentokil Initial plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTO#NYSE">RTO</a>) were down 21% to $24.98 after the company revised the guidance for the second half of FY24.</li>
<li>Torrid Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) was down, falling 24% to $5.06 after the company announced the launch of secondary offering of common stock.</li>
</ul>
Commodities In commodity news, oil traded up 3.2% to $67.87 while gold traded up 0.4% at $2,545.10.
Silver traded up 1.2% to $28.970 on Wednesday, while copper rose 1.1% to $4.1440.
Euro zone
European shares closed mixed today. The eurozone's STOXX 600 rose 0.01%, Germany's DAX gained 0.35% and France's CAC 40 fell 0.14%. Spain's IBEX 35 Index rose 0.67%, while London's FTSE 100 fell 0.15%.
The UK&#8217;s trade deficit widened to £7.51 billion in July from £5.32 billion in the previous month, while industrial production fell 0.8% month-over-month in July. The UK's economy stalled during the month of July compared to market estimates of a 0.2% increase.
Asia Pacific Markets
Asian markets closed lower on Wednesday, with Japan's Nikkei 225 falling 1.49%, Hong Kong's Hang Seng Index falling 0.73%, China's Shanghai Composite Index dipping 0.82% and India's BSE Sensex falling 0.49%.
The Reuters Tankan sentiment index for manufacturers in Japan declined to a reading of +4 in September compared to August's reading of +10. China&#8217;s vehicle sales dipped by 5.0% year-over-year to 2.45 million units for the month of August.
Economics
<ul>
<li>U.S. mortgage applications increased 1.4% in the week ending Sept. 6, compared to a 1.6% rise in the prior period.</li>
<li>U.S. annual inflation rate eased for a fifth straight month to 2.5% in August from 2.9% in the previous month, and down from market estimates of 2.6%.</li>
<li>The EIA said crude oil inventories in the U.S. increased by 0.833 million barrels during the week ended Sept. 6, compared to market estimates of a 1 million rise.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40792510/jim-cramer-says-aes-is-very-inexpensive-recommends-buying-this-industrial-stock">Jim Cramer Says AES Is &#8216;Very Inexpensive&#8217;, Recommends Buying This Industrial Stock</a></li>
</ul>

BCTX

CURV

LQDA

Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase

U.S. stocks traded mostly lower midway through trading, with the S&amp;P 500 falling around 0.5% on Wednesday.
The Dow traded down 0.94% to 40,352.38 while the NASDAQ rose 0.17% to 17,054.94. The S&amp;P 500 also fell, dropping, 0.52% to 5,466.77.
Check This Out: <a href="https://www.benzinga.com/news/24/09/40812617/wall-streets-most-accurate-analysts-give-their-take-on-3-materials-stocks-delivering-high-dividend-y">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Information technology shares fell by just 0.3% on Wednesday.
In trading on Wednesday, financials shares dipped by 2.4%.
Top Headline
U.S. annual inflation rate eased for a fifth straight month to 2.5% in August from 2.9% in the previous month, and down from market estimates of 2.6%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) shares shot up 32% to $6.18 after the company announced financing transaction and Ironton production update.</li>
<li>Shares of BriaCell Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCTX#NASDAQ">BCTX</a>) got a boost, surging 109% to $1.3010 after the company announced overall survival data of its Phase 2 clinical study of Bria-IMT in combination with an immune check point inhibitor in late stage metastatic breast cancer.</li>
<li>Sigma Lithium Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) shares were also up, gaining 15% to $10.77 amid a rise in the price of lithium. Chinese company Contemporary Amperex Technology halted production at its lepidolite mine in Yichun, Jiangxi.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares dropped 58% to $1.58 after the company announced that it has notified the Nasdaq Stock Market of its decision to delist.</li>
<li>Shares of Rentokil Initial plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTO#NYSE">RTO</a>) were down 21% to $24.85 after the company revised the guidance for the second half of FY24.</li>
<li>Torrid Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) was down, falling 26% to $4.95 after the company announced the launch of secondary offering of common stock.</li>
</ul>
Commodities In commodity news, oil traded up 2.5% to $67.37 while gold traded down 0.4% at $2,533.20.
Silver traded down 0.1% to $28.585 on Wednesday, while copper rose 0.6% to $4.1235.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.01%, Germany's DAX gained 0.57% and France's CAC 40 fell 0.21%. Spain's IBEX 35 Index rose 0.62%, while London's FTSE 100 fell 0.20%.
The UK&#8217;s trade deficit widened to £7.51 billion in July from £5.32 billion in the previous month, while industrial production fell 0.8% month-over-month in July. The UK's economy stalled during the month of July compared to market estimates of a 0.2% increase.
Asia Pacific Markets
Asian markets closed lower on Wednesday, with Japan's Nikkei 225 falling 1.49%, Hong Kong's Hang Seng Index falling 0.73%, China's Shanghai Composite Index dipping 0.82% and India's BSE Sensex falling 0.49%.
The Reuters Tankan sentiment index for manufacturers in Japan declined to a reading of +4 in September compared to August's reading of +10. China&#8217;s vehicle sales dipped by 5.0% year-over-year to 2.45 million units for the month of August.
Economics
<ul>
<li>U.S. mortgage applications increased 1.4% in the week ending Sept. 6, compared to a 1.6% rise in the prior period.</li>
<li>U.S. annual inflation rate eased for a fifth straight month to 2.5% in August from 2.9% in the previous month, and down from market estimates of 2.6%.</li>
</ul>

Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40792510/jim-cramer-says-aes-is-very-inexpensive-recommends-buying-this-industrial-stock">Jim Cramer Says AES Is &#8216;Very Inexpensive&#8217;, Recommends Buying This Industrial Stock</a></li>
</ul>

SGML

Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge

U.S. stocks traded mostly lower this morning, with the Dow Jones falling around 350 points on Wednesday.
The Dow traded down 0.87% to 40,384.56 while the NASDAQ rose 0.05% to 17,034.56. The S&amp;P 500 also fell, dropping, 0.41% to 5,473.12.
Check This Out: <a href="https://www.benzinga.com/news/24/09/40812617/wall-streets-most-accurate-analysts-give-their-take-on-3-materials-stocks-delivering-high-dividend-y">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Information technology shares surged by 0.9% on Wednesday.
In trading on Wednesday, real estate shares fell by 1.5%.
Top Headline
U.S. annual inflation rate eased for a fifth straight month to 2.5% in August from 2.9% in the previous month, and down from market estimates of 2.6%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>CN Energy Group. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>) shares shot up 190% to $0.8101.</li>
<li>Shares of BriaCell Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCTX#NASDAQ">BCTX</a>) got a boost, surging 165% to $1.66 after the company announced overall survival data of its Phase 2 clinical study of Bria-IMT in combination with an immune check point inhibitor in late stage metastatic breast cancer.</li>
<li>Tantech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) shares were also up, gaining 48% to $0.2052.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares dropped 61% to $1.4993 after the company announced that it has notified the Nasdaq Stock Market of its decision to delist.</li>
<li>Shares of Laser Photonics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASE#NASDAQ">LASE</a>) were down 21% to $7.22.</li>
<li>Torrid Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) was down, falling 27% to $4.85 after the company announced the launch of secondary offering of common stock.</li>
</ul>
Commodities In commodity news, oil traded up 1.7% to $66.85 while gold traded down 0.3% at $2,535.90.
Silver traded up 0.9% to $28.88 on Wednesday, while copper rose 1.2% to $4.1475.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.6%, Germany's DAX gained 0.8% and France's CAC 40 rose 0.5%. Spain's IBEX 35 Index rose 1%, while London's FTSE 100 rose 0.3%.
The UK&#8217;s trade deficit widened to £7.51 billion in July from £5.32 billion in the previous month, while industrial production fell 0.8% month-over-month in July. The UK's economy stalled during the month of July compared to market estimates of a 0.2% increase.
Asia Pacific Markets
Asian markets closed lower on Wednesday, with Japan's Nikkei 225 falling 1.49%, Hong Kong's Hang Seng Index falling 0.73%, China's Shanghai Composite Index dipping 0.82% and India's BSE Sensex falling 0.49%.
The Reuters Tankan sentiment index for manufacturers in Japan declined to a reading of +4 in September compared to August's reading of +10. China&#8217;s vehicle sales dipped by 5.0% year-over-year to 2.45 million units for the month of August.
Economics
<ul>
<li>U.S. mortgage applications increased 1.4% in the week ending Sept. 6, compared to a 1.6% rise in the prior period.</li>
<li>U.S. annual inflation rate eased for a fifth straight month to 2.5% in August from 2.9% in the previous month, and down from market estimates of 2.6%.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40792510/jim-cramer-says-aes-is-very-inexpensive-recommends-buying-this-industrial-stock">Jim Cramer Says AES Is &#8216;Very Inexpensive&#8217;, Recommends Buying This Industrial Stock</a></li>
</ul>

LASE

TANH

Dow Tumbles 350 Points; US Inflation Rate Slows In August

Press Releases

Telesis Bio Announces Reverse Stock Split

Telesis Bio Reports First Quarter 2024 Financial Results

Vicore Expands and Strengthens its Board of Directors

Telesis Bio Reports Second Quarter and First Half 2024 Financial Results

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market

Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis

Technical Explosions: DUO, KTTA, TBIO, GOTU – Watch Peraso Inc. (NASDAQ: PRSO) Now Amid Breakout Momentum!

Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis

Comments

Telesis Bio

Telesis Bio (TBIO) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO